The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ACADIA PHARMACEUTICALS INC | COM | 004225108 | 28,018 | 1,156,817 | SH | SOLE | 1,156,817 | 0 | 0 | ||
ALLAKOS INC | COM | 01671P100 | 838 | 147,189 | SH | SOLE | 147,189 | 0 | 0 | ||
AMARIN CORP PLC | SPONS ADR NEW | 023111206 | 13,598 | 4,133,237 | SH | SOLE | 4,133,237 | 0 | 0 | ||
ANNEXON INC | COM | 03589W102 | 3,410 | 1,249,143 | SH | SOLE | 1,249,143 | 0 | 0 | ||
ARGENX SE | SPONSORED ADR | 04016X101 | 39,175 | 124,244 | SH | SOLE | 124,244 | 0 | 0 | ||
ASTRIA THERAPEUTICS INC | COM | 04635X102 | 6,118 | 911,736 | SH | SOLE | 911,736 | 0 | 0 | ||
AXSOME THERAPEUTICS INC | COM | 05464T104 | 39,013 | 942,571 | SH | SOLE | 942,571 | 0 | 0 | ||
BIOHAVEN PHARMACTL HLDG CO | COM | G11196105 | 28,375 | 239,314 | SH | SOLE | 239,314 | 0 | 0 | ||
COGENT BIOSCIENCES INC | COM | 19240Q201 | 11,677 | 1,558,975 | SH | SOLE | 1,558,975 | 0 | 0 | ||
ENANTA PHARMACEUTICALS INC | COM | 29251M106 | 33,402 | 469,264 | SH | SOLE | 469,264 | 0 | 0 | ||
GLOBAL BLOOD THERAPEUTICS IN | COM | 37890U108 | 40,955 | 1,182,307 | SH | SOLE | 1,182,307 | 0 | 0 | ||
INSMED INC | COM PAR $.01 | 457669307 | 45,796 | 1,948,784 | SH | SOLE | 1,948,784 | 0 | 0 | ||
INSTIL BIO INC | COM | 45783C101 | 7,244 | 673,905 | SH | SOLE | 673,905 | 0 | 0 | ||
IOVANCE BIOTHERAPEUTICS INC | COM | 462260100 | 6,487 | 389,588 | SH | SOLE | 389,588 | 0 | 0 | ||
KEROS THERAPEUTICS INC | COM | 492327101 | 21,584 | 396,911 | SH | SOLE | 396,911 | 0 | 0 | ||
NUVALENT INC | COM | 670703107 | 18,590 | 1,338,393 | SH | SOLE | 1,338,393 | 0 | 0 | ||
OLEMA PHARMACEUTICALS INC | COM | 68062P106 | 11,371 | 2,669,300 | SH | SOLE | 2,669,300 | 0 | 0 | ||
POINT BIOPHARMA GLOBAL INC | COM | 730541109 | 18,431 | 2,312,523 | SH | SOLE | 2,312,523 | 0 | 0 | ||
PROTAGONIST THERAPEUTICS INC | COM | 74366E102 | 13,024 | 549,988 | SH | SOLE | 549,988 | 0 | 0 | ||
TYRA BIOSCIENCES INC | COM | 90240B106 | 13,749 | 1,284,990 | SH | SOLE | 1,284,990 | 0 | 0 | ||
VERONA PHARMA PLC | SPONSORED ADS | 925050106 | 4,624 | 926,602 | SH | SOLE | 926,602 | 0 | 0 | ||
VIRIDIAN THERAPEUTICS INC | COM | 92790C104 | 17,456 | 944,092 | SH | SOLE | 944,092 | 0 | 0 |